Osaic Holdings’s Iterum Therapeutics ITRM Stock Holding History

Osaic Holdings’s Portfolio ITRM Stock Details ITRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-993	Closed	-$29	–	8088
2026 Q1	$29	Buy	+993	New	+$249	﹤0.01%	7705
2024 Q3	–	Sell	-12	Closed	-$13	–	7484
2024 Q2	$13	Hold	12	–	–	﹤0.01%	7349
2024 Q1	$18	Hold	12	–	–	﹤0.01%	7129
2023 Q4	$23	Sell	12 -12	-50%	-$15	﹤0.01%	7200
2023 Q3	$19	Buy	24 +12	+100%	+$11	﹤0.01%	7320
2023 Q2	$12	Hold	12	–	–	﹤0.01%	7397
2023 Q1	$11	Hold	12	–	–	﹤0.01%	7449
2022 Q4	$0	Hold	12	–	–	﹤0.01%	7309
2022 Q3	$0	Sell	12 -73	-86%	-$222	﹤0.01%	7383
2022 Q2	$0	Hold	85	–	–	﹤0.01%	7475
2022 Q1	$201K	Hold	85	–	–	﹤0.01%	4025
2021 Q4	$0	Hold	85	–	–	﹤0.01%	7474
2021 Q3	$1K	Sell	85 -134	-61%	-$1.65K	﹤0.01%	7031
2021 Q2	$7K	Hold	219	–	–	﹤0.01%	6249
2021 Q1	$5K	Buy	+219	New	+$5.21K	﹤0.01%	6152

Other funds holding ITRM

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

CCMW

Cypress Capital Management (Wyoming) Sheridan, Wyoming $120M AUM 63.01% 1-Year Est. Return

Osaic Holdings's ITRM Position: Q2 2026 in Review

Osaic Holdings sold out of Iterum Therapeutics (ITRM) in Q2 2026, closing a stake of 993 shares — an estimated $29 sold.

Osaic Holdings first reported a position in ITRM in Q1 2021 and held it in 15 quarters. The position peaked at $201K in Q1 2022. 2 funds tracked by Wall St. Rank hold ITRM as of Q2 2026.

Osaic Holdings reported no remaining Iterum Therapeutics position as of Q2 2026 after selling out during the quarter.
Osaic Holdings sold 993 Iterum Therapeutics shares in Q2 2026, an estimated $29.
Osaic Holdings first reported a position in Iterum Therapeutics in Q1 2021 and held it in 15 quarters.
Osaic Holdings's Iterum Therapeutics position peaked at $201K in Q1 2022.
2 funds tracked by Wall St. Rank held Iterum Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.